Paul de Laat

Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation

Paul de Laat, Saskia Koene, Lambert P. W. J. den van Heuvel et al. · Journal of Inherited Metabolic Disease · 2012 · 143 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Posterior reversible encephalopathy syndrome in childhood cancer

Paul de Laat, M.L. te Winkel, Annick S. Devos et al. · Annals of Oncology · 2010 · 110 citations · Full text

Medicine, Oncology, Pediatrics +5

Mitochondrial Retinal Dystrophy Associated with the m.3243A>G Mutation

Paul de Laat, Mirian C. H. Janssen, Jan E.E. Keunen et al. · Ophthalmology · 2013 · 85 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

The <scp>KHENERGY</scp> Study: Safety and Efficacy of <scp>KH</scp>176 in Mitochondrial m.3243A&gt;G Spectrum Disorders

Mirian C. H. Janssen, Saskia Koene, Paul de Laat et al. · Clinical Pharmacology & Therapeutics · 2018 · 56 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +16

Serum GDF15 Levels Correlate to Mitochondrial Disease Severity and Myocardial Strain, but Not to Disease Progression in Adult m.3243A&gt;G Carriers

Saskia Koene, Paul de Laat, Doorlène H. van Tienoven et al. · JIMD Reports · 2015 · 41 citations · Full text

Medicine, Cardiology, Molecular Genetics +16